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1  | INTRODUC TION
The evaluation of semen quality has been based on the results pro-
vided by the standard semen analysis since its introduction in the 
andrological practice. However, semen parameters do not determine 
the true fertility potential of an individual in 15% of cases (Hamada, 
Esteves, Nizza, & Agarwal, 2012), while physical examination, labo-
ratory work and semen analysis fail to identify the etiology in 30%-
40% of patients, those are classified as idiopathic male infertility 
(Bracke, Peeters, Punjabi, Hoogewijs, & Dewilde, 2018). Proteomics 
and metabolomics are the two new emerging -OMICS platforms 
used for the identification of new markers to define the male fer-
tility potential, with an increasing number of publications over the 
last two decades (Agarwal, Baskaran, Panner Selvam, Barbarosie, & 
Master, 2020; Baskaran et al., 2019).
Complete profiling of proteins present in a tissue or a cell is 
defined as proteomics. Shotgun or bottom-up approaches are the 
most widely used in the field of proteomics, and they can detect 
more than 1,000 proteins in a given sample. In the field of male 
infertility, semen is the most commonly used biological fluid to eval-
uate the fertility status of men. Semen contains cellular and non-
cellular components, that is spermatozoa and seminal plasma, which 
can be investigated by applying proteomics techniques (Jodar, Soler-
Ventura, & Oliva, 2017; Panner Selvam & Agarwal, 2018; Sinha, 
Singh, & Yadav, 2017). Amaral et al. used a data mining approach 
to identify 6,198 proteins in human spermatozoa (Amaral, Castillo, 
Ramalho-Santos, & Oliva, 2014), whereas 2064 proteins were iden-
tified in the seminal plasma (Jodar et al., 2017). Considering that 
spermatozoa are transcriptionally and translationally inert, they 
rely on proteins for their functional activity. Defects in the normal 
physiological functions of spermatozoa are observed due to alter-
ations in the spermatozoa and seminal plasma proteome, and they 
are associated with male infertility conditions such as varicocele 
(Agarwal, Sharma, Durairajanayagam, Ayaz et al., 2015; Agarwal, 
Sharma, Durairajanayagam, Cui, et al., 2015; Agarwal, Sharma, 
Harlev, & Esteves, 2016; Belardin et al., 2016; Mariana Camargo, 
Intasqui, & Bertolla, 2016; Samanta et al., 2018), idiopathic infertility 
(Herwig et al., 2013; Hetherington et al., 2016; Shen, Wang, Liang, 
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Abstract
Proteomics and metabolomics are emerging as promising tools to investigate the mo-
lecular mechanisms associated with male infertility. Proteins and metabolites play a 
pivotal role in regulating the molecular pathways associated with physiological func-
tions of spermatozoa. Semen analysis, physical examination and laboratory work up 
cannot identify the etiology of infertility in 30%-40% of cases, which are classified 
as idiopathic. Therefore, the application of proteomics and metabolomics in the field 
of andrology will aid to overcome the limitations of the standard semen analysis. 
Understanding the molecular pathways associated with male infertility will help 
in planning ad hoc treatments, contributing to the clinical management of infertile 
patients. In this review, proteomics and metabolomics studies on spermatozoa and 
seminal plasma are discussed with a focus on molecular biomarkers associated with 
male infertility-related conditions.
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& He, 2013), unexplained male infertility (UMI) (Azpiazu et al., 2014; 
Liu, Liu, et al., 2018; McReynolds et al., 2014; Xu et al., 2012), ele-
vated oxidative stress (Ayaz et al., 2015; Hamada et al., 2013; Sharma 
et al., 2013) and testicular cancer (Agarwal, Tvrda, et al., 2015; Dias, 
Agarwal, Pushparaj, Ahmad, & Sharma, 2018). Key proteins asso-
ciated with sperm functions such as hyperactivation, capacitation, 
acrosome reaction and the fertilization process can be used as 
non-invasive biomarkers in the pathophysiology of male infertility.
2  | TECHNIQUES IN PROTEOMIC S
Sperm proteins are detected and identified using different prot-
eomic techniques. The conventional approach includes the separa-
tion of the extracted spermatozoa or seminal plasma proteins based 
on properties such as molecular weight and isoelectric point using 
two-dimensional (2D) gel electrophoresis. A total of 98 human 
sperm proteins were separated using 2D-gel electrophoresis and 
identified by matrix-assisted laser desorption/ionisation time-of-
flight (MALDI-TOF) technique. These proteins were involved in 
transcription, energy production and protein synthesis (Martínez-
Heredia, Estanyol, Ballescà, & Oliva, 2006). Difference gel elec-
trophoresis (DIGE), an improved version of 2D-gel electrophoresis 
technique, is able to identify differentially expressed proteins (DEPs) 
with a minimum error of < 10% (Gupta, Ghulmiyyah, Sharma, Halabi, 
& Agarwal, 2014). The expression profile of the proteins is deter-
mined based on the intensity of Cy3 and Cy5 dyes using automated 
image analysis software.
Low sensitivity and the inability to detect less abundant proteins 
or low number of proteins are some of the limitations of conven-
tional proteomic techniques. These limitations were overcome by 
using advanced high-throughput techniques such as MALDI-TOF 
and LC-MS/MS (liquid chromatography–tandem mass spectrom-
etry). These instruments can even detect low abundance peptides 
present in a sample with low protein concentration. Johnston et al. 
used in-gel digestion-based LC-MS/MS approach to identify 1,760 
sperm proteins (Johnston, Wooters, Kopf, Qiu, & Roberts, 2005), 
and the same approach was widely used to profile the spermato-
zoa of infertile men (Cao et al., 2018; Dias et al., 2018; Giacomini 
et al., 2015; Liu, Liu, et al., 2018).
Additional purification of seminal plasma is not required as they 
are rich in proteins and are readily available for proteomic exper-
iments. Semen samples undergo purification and processing steps 
prior to the extraction of sperm proteins. Semen samples are sub-
jected to different types of processing techniques such as single 
gradient centrifugation, double gradient centrifugation or multilayer 
gradient centrifugation to separate the spermatozoa from the sem-
inal plasma. Several studies have used a density gradient centrif-
ugation step to remove round cells and immature germ cells from 
semen samples to isolate a pure sperm fraction (Amaral, Paiva, 
et al., 2014; Intasqui et al., 2013; Martínez-Heredia et al., 2006; 
Wang et al., 2014, 2018). Further, proteomic studies on round cells 
and spermatozoa revealed that the influence of round cell proteins 
as contaminant in the sperm proteome was insignificant or very neg-
ligible (Panner Selvam, Agarwal, Dias et al., 2019; Panner Selvam, 
Agarwal, Dias, Martins, & Samanta, 2019). The presence of these 
round cell proteins does not interfere with the bioinformatics results 
related to the molecular pathways associated with sperm function.
In general, extraction of proteins using RIPA buffer provides 
maximum yield of proteins compared to other techniques such as 
sonication. Incubation of spermatozoa overnight with RIPA buf-
fer results in the lysis of sperm membrane and release of proteins. 
Subsequently, the proteins are pelleted and washed 3 times with 
RIPA solution to remove cell debris. The concentration and purity 
of the sperm proteins are determined before they are subjected to 
proteomic analysis. A known amount of protein is separated using 
4% to 15% SDS-PAGE, and in-gel digestion of the separated pro-
teins is done using trypsin. Digested peptides are eluted from the 
gel and injected into mass spectrometry (Glish & Vachet, 2003). The 
instrument detects the proteins or peptides based on mass/charge 
ratio (m/z) with a very low false discovery rate. Enrichment of sperm 
proteins by immunoprecipitation is the most preferred protocol for 
purifying the acetylated, methylated and phosphorylated proteins 
for post-translational modification studies. Other advanced tech-
niques such as MALDI-TOF and SELDI-TOF (surface-enhanced laser 
desorption/ionisation time-of-flight) are also used to detect the 
sperm proteins (Bracewell-Milnes et al., 2017; Rødgaard, Heegaard, 
& Callesen, 2015).
Computational software such as SEQUEST, Mascot X!, Tandem 
and MaxQuant (Zhou, Zhou, & Guo, 2013) is used to identify the 
peptides and proteins. These computational tools perform a com-
plete scan of proteins detected by MS and compare it with already 
available global databases for the human proteome. Further, the 
proteins are categorised as DEPs based on spectral counts (SC) and 
abundance of each protein. Bioinformatic analysis provides insight 
into the functional and molecular mechanisms based on the pro-
teomic data (Lan et al., 2003). Gene ontology (GO) analysis of the 
proteins provides information about their localization, distribution 
and biological functions. Protein–protein interactions and defective 
molecular pathways can be identified using sophisticated programs 
such as Ingenuity Pathway Analysis (IPA) and Metacore™. STRING 
(Search Tool for the Retrieval of Interacting Genes/Proteins) analy-
sis is commonly performed to display the link between the proteins 
(Agarwal et al., 2014).
3  | PROTEOMIC S IN DECIPHERING KE Y 
PROTEINS A SSOCIATED WITH MALE 
REPRODUC TION
Alteration in the expression profile of key proteins involved in the 
cellular and molecular pathways in the spermatozoa can be iden-
tified using proteomics (du Plessis, Kashou, Benjamin, Yadav, & 
Agarwal, 2011). Particularly, proteomics can be applied to analyse 
the whole sperm proteome as well as protein expression in subcellu-
lar compartments. Furthermore, the same approach can be used for 
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seminal plasma and testicular tissue, as explained in the subsequent 
sections.
3.1 | Whole sperm proteomics
Several investigators have characterised the proteome from whole 
sperm cells in normozoospermic men. In 2006, Martinez-Heredia 
et al. identified 98 proteins in normozoospermic men by using 2-DE 
and MALDI-TOF MS analysis, mainly structural proteins or involved 
in regulation of energy metabolism, protein synthesis, cellular cycle, 
apoptosis and cellular movement, as well as in the response to the 
oxidative stress (Martínez-Heredia et al., 2006). Nowicka-Bauer 
et al. identified 73 proteins involved in energy metabolism using 
2-DE and MS (Nowicka-Bauer et al., 2018). They also reported 25 
proteins for the first time in spermatozoa, including ANXA7, a cal-
cium-dependent phospholipid binding protein localized in the sperm 
membrane, and c14orf105, still uncharacterized protein in the sperm 
nucleus. Proteomic profile of the spermatozoa differs among its 
subsets. Global proteomics has been conducted on different frac-
tions of spermatozoa (mature and immature) from fertile and infer-
tile men (Cui, Sharma, & Agarwal, 2016; Samanta, Sharma, Cui, & 
Agarwal, 2018). A higher expression of proteins involved in protein 
biosynthesis, transport and ubiquitination as well as in the cellular 
response to oxidative stress was observed in immature spermatozoa 
(Cui et al., 2016). In spermatozoa of infertile men, the most mature 
sperm fraction showed an altered expression of proteins involved in 
energy-related signalling cascade as well as protein folding (Samanta 
et al., 2018).
Whole sperm proteomics involves the characterization and pro-
filing of proteins and peptides extracted from the spermatozoa. It has 
been investigated in several infertility-related conditions. Intasqui 
et al. analyzed the proteomic profile of spermatozoa in men with pri-
mary and secondary infertility (Intasqui, Agarwal, Sharma, Samanta, 
& Bertolla, 2018), and reported a total of 117 DEPs when compared 
to proven fertile men. Furthermore, BAG6 and HIST1H2BA were 
proposed as potential markers for male infertility. These proteins 
are involved in post-translational modifications and folding of pro-
teins as well as in histones replacement by protamines, respectively 
(Intasqui et al., 2018).
3.1.1 | Subcellular proteomics
Proteomics studies on the whole cellular lysate do not provide suf-
ficient information regarding function of the proteins localized in 
subcellular compartments or organelles of spermatozoa. Proteomic 
analysis of the proteins selectively extracted from the organelles of 
spermatozoa provides further information about the subcellular me-
tabolism (Sadowski et al., 2006). In fact, the differential expression 
of proteins in subcellular compartments such as nucleus, acrosome 
and flagella is directly related to the function of spermatozoa (Amaral 
et al., 2013; Baker et al., 2013; Gu et al., 2011; Kim et al., 2007; de 
Mateo, Castillo, Estanyol, Ballescà, & Oliva, 2011; Naaby-Hansen & 
Herr, 2010; Stein, Go, Lane, Primakoff, & Myles, 2006). The sperm 
nuclear proteome is extracted by treatment of the sperm cells with 
the detergent cetyl trimethyl ammonium bromide (CTAB), to avoid 
any contamination from the flagella, mitochondria and acrosome re-
gion. De Mateo et al. analysed the nuclear proteins by 2D-PAGE and 
LC-MS/MS (de Mateo et al., 2011) and identified that histones and 
chromatin-related proteins are involved in the epigenetic regulation 
of spermatozoa, fertilisation and embryo development. A total num-
ber of 521 and 721 proteins were reported to be uniquely expressed 
in the head and tail of spermatozoa, respectively (Baker et al., 2013). 
Specifically, the flagellar subcompartment was enriched in metabolic 
proteins involved in pathways associated with the energy generation, 
such as glycolysis, gluconeogenesis, the Krebs cycle and the oxida-
tive phosphorylation as well as metabolism of fatty acids and amino 
acids, in agreement with the role of sperm tail in motility (Amaral 
et al., 2013; Kim et al., 2007). Proteins localized in the sperm head 
were mainly proteases, kinases and proteins involved in signalling 
pathways (Baker et al., 2013), whereas proteins mediating capacita-
tion, acrosomal reaction and oocyte binding were also described (Gu 
et al., 2011; Naaby-Hansen & Herr, 2010; Stein et al., 2006).
3.1.2 | Sperm surface proteomics
Sperm recognize the zona pellucida with the help of binding pro-
teins expressed on sperm surface, which also regulate the induction 
of the acrosome reaction. Therefore, the proteins expressed on the 
membrane are essential in the zona penetration and fertilization. 
Furthermore, membrane composition is the result of the complex 
process involved in spermatogenesis and its analysis can be informa-
tive regarding the sperm differentiation and maturation. Sperm cells 
are first lysed to purify the plasma membrane proteins. This can be 
achieved by sonication or nitrogen cavitation techniques in combi-
nation with differential centrifugations to isolate the different cel-
lular component (Zhou & Philips, 2017). It is possible to selectively 
extract peripheral membrane proteins by treating the lysate with 
high concentration of salt or specific detergents to extract the lipid 
drafts. Shetty et al. analyzed the sperm surface proteome in order 
to identify candidates for generating a contraceptive vaccine (Shetty 
et al., 2001). Expression of angiotensin-converting enzyme (ACE) 
on sperm membrane was identified by labelling proteins with sulfo-
NHS-LC-biotin before 2D-gel electrophoresis and microsequencing. 
Domagala et al. applied proteomics techniques to identify immuno-
reactive antigens on sperm surface (Domagala, Pulido, Kamieniczna, 
Kurpisz, & Herr, 2011), in order to decipher the proteins involved 
in the generation of an autoimmune response against spermatozoa. 
They confirmed the expression of sperm antigens, such as L-lactate 
dehydrogenase C chain and GAPDH2, as well as other new intrinsic 
and surface antigens, such as the clathrin heavy chain.
Lipid drafts are domains in the plasma membrane where pro-
teins involved in the same pathway co-localize in association with 
cholesterol and sphingolipids. Nixon et al. reported that these 
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proteins particularly mediate the binding to the zona pellucida and 
the further fusion of sperm membrane with the oolemma (Nixon 
et al., 2011). A total number of 124 proteins were identified in 
the sperm membrane lipid drafts by using a nano-LC/MS/MS ap-
proach. ACE, integrin beta-2, sperm adhesion molecule 1, SPA17 
and arylsulphatase A proteins involved in sperm–oocyte binding 
and adhesion, while proteins involved in cellular signalling, protein 
folder and intracellular transfer were identified on sperm mem-
brane (Nixon et al., 2011).
3.2 | Seminal plasma proteomics
Seminal plasma is a heterogeneous fluid composed by secre-
tions from organs and glands of the reproductive male tract. It 
has been estimated that 23% of the studies on proteomics in the 
male reproductive field in the last 20 years have been conducted 
on seminal plasma (Agarwal et al., 2020). The first study analyz-
ing the seminal proteome in healthy men was published in 2006 
(Pilch & Mann, 2006). By using LC-MS/MS analysis, authors re-
ported the expression of 923 proteins, such as FN1, SEMG1 and 2, 
lactoferrin and laminin. When the seminal proteome was analysed 
by HPLC coupled with MS, 83 proteins were reported to be com-
monly expressed in 5 fertile men, all of them involved in the male 
fertility-related pathways, such as SEMG I and II (participating in 
the formation of coagulum after the ejaculation), lactoferrin (acting 
as an immune-modulatory protein and also having antibacterial and 
antioxidant properties) and clusterin (previously described to be in-
volved in sperm agglutination) (Milardi et al., 2012). By classifying 
normozoospermic patients based on the values of sperm mitochon-
drial activity, acrosome integrity and sperm DNA fragmentation, 
Intasqui et al. proposed a set of seminal biomarkers associated with 
each of these alterations (Intasqui et al., 2016). Alterations of mi-
tochondrial activity were associated with an increased expression 
of ANXA7, glutathione S-transferase Mu3 and endoplasmic re-
ticulum resident protein 44; increased expression of the phospho-
lipid transfer protein was associated with acrosome defects, while 
CRISPLD1, CRISPLD2 and retinoic acid receptor responder protein 
1 were proposed as markers of sperm DNA damage.
A variation in seminal proteome was observed in normozoosper-
mic patients classified according to the levels of semen lipid peroxi-
dation, measured by thiobarbituric acid assay (Intasqui et al., 2015). 
By using LC-MS/MS analysis, oxidative stress was reported to in-
fluence seminal proteome, by inducing an increased expression of 
proteins related to the biosynthesis of unsaturated fatty acids, and 
response to oxidative, immune and heat stress. These preliminary 
observations have been further strengthen by the report of 44 DEPs 
in fertile men classified regarding the concentration of seminal ROS, 
detected by chemiluminescence (Dias et al., 2019). Particularly, fer-
tile men having high ROS concentration expressed higher levels of 
SOD1 and PRDX4, antioxidants systems to counterbalance the ox-
idant levels and proteins involved in the degradation of defective 
proteins.
3.3 | Testicular proteomics
Proteomic research conducted on testicular tissue is very lim-
ited. Very few articles have been published using testicular tissue 
in the last 20 years (Agarwal et al., 2020). Testicular proteome 
provides substantial understanding about the cellular signalling 
pathways that are significantly altered in pathological condi-
tions, such as obstructive and non-obstructive azoospermia, and 
testicular cancer (Alikhani et al., 2017; Leman et al., 2009; Liu 
et al., 2013). Future proteomics studies on testicular tissue will 
help in the investigation of proteins involved in spermatogenesis 
and to identify novel targets for treatment of male infertility (Li 
et al., 2011).
4  | THE IMPAC T OF CRYOPRESERVATION 
ON SPERM PROTEOMIC S
Semen cryopreservation is a procedure performed routinely 
to preserve the spermatozoa for future use in ART procedures. 
Cryopreservation has been correlated with reduced semen qual-
ity, particularly decreased motility, viability and acrosome integ-
rity (Ozkavukcu, Erdemli, Isik, Oztuna, & Karahuseyinoglu, 2008). 
Bogle et al. also reported the alteration of sperm proteome de-
pending on the use of cryoprotectant (protein-free cryosperm me-
dium) and the freezing/thawing procedure itself, potentially due 
to the induction of protein degradation and osmotic stress (Bogle 
et al., 2017). Proteomics analysis of cryopreserved spermatozoa 
showed altered expression of proteins involved in reproductive 
function pathways, such as energy metabolism (ACO2, ENO1), 
the maintenance of cell surface integrity (vimentin) and the flagel-
lar structural integrity (TEKT1) (Wang et al., 2014). Also, higher 
levels of global tyrosine phosphorylation were reported in fro-
zen spermatozoa, in association with alteration of sperm motility, 
sperm functions and a premature induction of capacitation (Wang 
et al., 2014). The investigation of the altered pathways in sperma-
tozoa after cryopreservation may be of outstanding importance 
for the creation of specific cryoprotectants having a low impact on 
sperm physiology and potentially improve the reproductive out-
comes after ART.
5  | PROTEOMIC S IN PROGNOSIS AND 
DIAGNOSIS OF MALE INFERTILIT Y
Over the last two decades, an increasing number of studies has 
been published about proteomics in male infertility-related clini-
cal scenarios such as varicocele, idiopathic infertility, testicular 
cancer, UMI and sperm abnormalities-related conditions (Agarwal 
et al., 2020). Research is mainly aimed to decipher the molecular 
mechanisms affecting the reproductive function of infertile men 
and to identify potential biomarkers for the diagnosis and treatment 
in clinical setting.
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5.1 | Potential biomarkers of varicocele
Varicocele is a vascular disease characterised by the enlargement 
of the pampiniform venous plexus (Miyaoka & Esteves, 2012). Few 
global proteomic studies have reported the key proteins and the al-
tered molecular mechanisms in male infertility-associated varicocele 
(Agarwal, Sharma, Samanta, Durairajanayagam, & Sabanegh, 2016; 
Ayaz et al., 2015; Panner Selvam & Agarwal, 2019; Panner Selvam, 
Agarwal, & Baskaran, 2019; Samanta et al., 2018). Reduced expres-
sion of proteins involved in mitochondrial (ATPase1A4) and cy-
toskeleton (SPA17) functionality and structure, as well as related 
to sperm functions (HSPA2, APOA1), was reported in varicocele 
sperm samples (Agarwal, Sharma, Samanta, et al., 2016; Hosseinifar 
et al., 2013; Samanta et al., 2018).
Panner Selvam & Agarwal (2019) showed an altered expression 
of 28 seminal plasma proteins in varicocele patients, mainly associ-
ated with oxidative stress response and sperm–oocyte membrane 
fusion, while other studies reported an alteration of seminal pro-
teins related to sperm maturation, sperm motility and capacitation 
(Fariello et al., 2012; Zylbersztejn et al., 2013). Varicocele correction 
resulted in an improved expression of seminal plasma proteins in-
volved in oxidative stress response, protein stabilization and gluco-
neogenesis (Fariello et al., 2012; Zylbersztejn et al., 2013; Camargo, 
Intasqui, & Pimenta Bertolla, 2016). Moreover, the expression of 
three proteins (HSPA5, SOD1 and ATP5D) involved in protein fold-
ing, oxidative stress response and energy generation increased after 
varicocele correction (Hosseinifar et al., 2014), with a shift towards 
the homeostasis (Camargo et al., 2013; Del Giudice et al., 2013).
A severe alteration of the sperm proteome was observed in bilat-
eral varicocele compared to unilateral varicocele (Agarwal, Sharma, 
Durairajanayagam, Cui, et al., 2015) as well as proteins associated 
with inflammatory response such as IL-6 and Jak-STAT pathways 
(Panner Selvam, Agarwal, Pushparaj, Baskaran, & Bendou, 2019).
Proteins such as ENKUR, SEMG1, SEMG2, SPAM1 and CABYR, 
involved in calcium transduction machinery, capacitation, acrosome 
reaction and in the formation of semen coagulum, were significantly 
overexpressed in bilateral varicocele patients (Agarwal, Sharma, 
Durairajanayagam, Cui, et al., 2015). Moreover, the overexpressed 
PRDX2 and FASN and the reduced FN1 seminal plasma proteins were 
suggested to differentiate bilateral from unilateral patients (Panner 
Selvam et al., 2019). Sperm proteins such as CRISP2 and ARG2 
were expressed uniquely in unilateral varicocele patients (Agarwal, 
Sharma, Durairajanayagam, Ayaz et al.,2015). CRISP2 is involved in 
calcium fluxes during the capacitation, while ARG2 was negatively 
associated with sperm concentration and positively with sperm 
motility (Cohen et al., 2011; Elgün, Kaçmaz, Sen, & Durak, 2000). 
Moreover, GNPDA1 was expressed only in unilateral patients, being 
involved in calcium oscillation triggering oocyte activation and 
embryo development (Agarwal, Sharma, Durairajanayagam, Cui, 
et al., 2015). The overexpression of proteins involved in antioxidant 
systems was also reported, suggesting the establishment of a reduc-
tive stress microenvironment in unilateral varicocele patients (Swain 
et al., 2019).
5.2 | Potential biomarkers of unexplained (UMI) and 
idiopathic male infertility
UMI is defined as a condition in which the semen parameters are 
normal (according to WHO 5th edition guidelines) but the cause of 
infertility is unknown (Hamada et al., 2012). Idiopathic infertile pa-
tients are those with altered semen parameters with an unknown 
cause (Aktan et al., 2013). Proteomics analysis of spermatozoa from 
infertile normozoospermic men revealed underexpression of pro-
teins (CRISP2, NME5, TSSK2, MYCBP, NDRG3, SPATA24, ROPN1L) 
involved in development/functions of male gametes (McReynolds 
et al., 2014). Moreover, proteins involved in response to the stress 
(HSPA2, HSPA5, STIP1, CLU) resulted to be overexpressed in case of 
poor blastocyst development and reduced implantation rate after in 
vitro fertilisation, suggesting them as potential molecular biomarkers 
for UMI (McReynolds et al., 2014). Other proteins such as the ANXA2, 
SPA17 and SERPINA5 were differentially expressed and proposed as 
potential biomarkers in UMI condition (Panner Selvam et al., 2019). 
SPA17 is involved in the acrosome reaction and oocyte fertilization 
(Chiriva-Internati et al., 2009), while SERPINA5 is mainly expressed in 
the head of spermatozoa, being involved in the sperm–oocyte bind-
ing (Yang & Geiger, 2017). Underexpression of both proteins (SPA17 
and SERPINA5) may significantly affect the male fertility potential. On 
the other hand, ANXA2 is reportedly overexpressed during abnormal 
ubiquitination (Deng, Jing, Xing, Hou, & Yang, 2012) and may affect 
the sperm functions. The proteins clusterin, epididymal secretory 
protein E1 (HE1) and PSA were proposed as seminal biomarkers for 
success in unexplained infertile couples undergoing IVF (Kanannejad 
& Gharesi-Fard, 2019). These proteins are correlated with the sperm 
quality. Clusterin protects the spermatozoa from oxidative stress and 
DNA damage, and regulates the sperm motility and viability (Salehi 
et al., 2013). HE1 is secreted by epididymis and plays a role in choles-
terol transport (Girouard, Frenette, & Sullivan, 2008), while the pros-
tatic PSA regulates semen liquefaction (Balk, Ko, & Bubley, 2003).
Agarwal et al. reported the changes in the sperm proteome of id-
iopathic infertile men treated with antioxidant supplementation (FH 
PRO for Men) (Agarwal et al., 2019). Besides the beneficial effect of 
FH PRO for Men on semen quality, it is also predicted to enhance the 
metabolic pathways involved in the energy production, spermato-
genesis, sperm functions and fertilization as well as increase cellular 
response to oxidative stress (Agarwal et al., 2019).
5.3 | Potential biomarkers of testicular cancer
Testicular cancer is common in men of reproductive age (15–40 years 
old) (Chia et al., 2010). It arises from malignant transformation of 
germ cells in 95% of cases, further subcategorized in seminomas 
(50%) and non-seminomas (50%) (Adra & Einhorn, 2017). Recently, 
Panner Selvam et al. reported an altered protein profile in sperma-
tozoa of testicular cancer patients, particularly protein regulators of 
sperm motility, oocyte binding, capacitation and fertilization, and 
have suggested putative molecular biomarkers associated with each 
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dysfunctional pathway (Panner Selvam, Agarwal, & Pushparaj, 2019). 
Proteomic analysis of testicular cancer tissue has revealed proteins 
like PIWIL1 (involved in DNA methylation and RNA silencing) and 
TMPRSS12 (a serine protease) as markers of testicular tumour germ 
cells (Liu et al., 2013). Furthermore, glutathione S-transferase M3 
was reported to be downregulated in case of seminoma and distinct 
polymorphisms associated with higher risk of cancer development 
(Zimmermann et al., 2006). Other putative markers identified in 
seminoma tissue by 2D-gel electrophoresis included the overex-
pression of GCP6 (microtubule nucleation) and CDK10 (cellular cycle 
regulator), as well as the underexpression of StarD7 (maintenance 
of the cellular shape) (Leman et al., 2009). Castillo et al. combined 
metal oxide affinity chromatography with LC-MS/MS to investigate 
testicular phosphoproteome and reported an overexpression of 
PAK4 protein in embryonal carcinoma (Castillo et al., 2019). PAK4 is 
involved in cellular proliferation, and its overexpression protects the 
cancer cells from the apoptosis.
5.4 | Potential biomarkers of sperm abnormalities
Proteomes have been analysed in several groups of sperm abnor-
malities. Protein pathways associated with sperm motility are com-
promised in asthenozoospermic patients (Hashemitabar, Sabbagh, 
Orazizadeh, Ghadiri, & Bahmanzadeh, 2015). The DEPs identified 
in asthenozoospermic patients were mainly associated with energy 
and metabolism, movement and structural organisation, stress re-
sponse, signalling and antioxidant activity (Martinez-Heredia, de 
Mateo, Vidal-Tboada, Ballesca, & Oliva, 2008; Siva et al., 2010; Zhao 
et al., 2007). Hashemitabar et al. reported a decreased expression 
of proteins involved in the ATP synthesis, suggesting the oxidative 
phosphorylation as the main pathway in regulating sperm motil-
ity (Hashemitabar et al., 2015). Further, the absence of structural 
proteins such as ODF2 and tektin 4 in sperm flagella suggests cy-
toskeleton alteration as the main cause of asthenozoospermia (Shen 
et al., 2013). However, Zhao et al. reported higher levels of ODF pro-
teins and a reduced expression of the 26S protease regulatory subu-
nit 7 in asthenozoospermic Asian cohort (Zhao et al., 2007), whereas 
the subunit PSMB3 component of proteasome complex was overex-
pressed in the European population (Martinez-Heredia et al., 2008), 
underlining difference in protein expression due to geographical 
origin. Moreover, lower levels of GRP78 in idiopathic asthenozoo-
spermic patients may be involved in a reduced sperm binding to zona 
pellucida, with consequences on sperm capacitation and fertilization 
(Shen et al., 2013). In addition to protein expression, post-transla-
tional modifications of proteins can adversely affect the sperm 
physiology (Baker, Witherdin, Hetherington, Cunningham-Smith, & 
Aitken, 2005). These include glycosylation, S-nitrosylation, sumoyla-
tion and phosphorylation (Lefièvre et al., 2007; Samanta, Swain, 
Ayaz, Venugopal, & Agarwal, 2016; Vigodner et al., 2013; Wang 
et al., 2013). Particularly, phosphorylation regulates sperm matu-
ration and capacitation (Ficarro et al., 2003). Asthenozoospermic 
spermatozoa showed a reduced level of protein phosphorylation, 
resulting in the alteration of the mitochondrial energy metabolism 
and fibrous sheath/cytoskeletal structure, and lower sperm motility 
(Chan et al., 2009; Parte et al., 2012).
Seminal proteins such as ECM1, TEX101 and NPC2 have been 
proposed to discriminate obstructive from non-obstructive azo-
ospermia (Drabovich et al., 2013; Yamakawa, Yoshida, Nishikawa, 
Kato, & Iwamoto, 2007). Freour et al. focused on the identification 
of biomarkers for the spermatozoa retrieval from testis in case of 
non-obstructive azoospermia and revealed higher expression of 
seminal LGALS3BP in men with successful TESE (Freour et al., 2013). 
Oligoasthenoteratozoospermic (OAT) patients showed altered semi-
nal expression of proteins involved in metabolism and inflammation, 
stress response and proteins associated with binding, transporter, 
immune and hydrolase activities (Giacomini et al., 2015; Herwig 
et al., 2013; Liu, Wang, et al., 2018). Recently, Liu et al. proposed 
KLK3, LTF SERPINA1 and GAPDH as putative biomarkers to dis-
criminate between OAT and normozoospermic patients (Liu, Wang, 
et al., 2018), besides the previously identified NPC2, M2BP and li-
pocalin-1 (Giacomini et al., 2015) (Table 1). Herwig et al. identified 
a panel of 46 proteins related to oxidative stress in patients with 
infertile idiopathic OAT (Herwig et al., 2013). These studies provided 
further insight into the molecular pathogenic mechanisms underly-
ing OAT condition.
The proteome of globozoospermia, a rare genetic condition 
characterised by the absence of acrosome, has also been investi-
gated. Comparative analysis of sperm proteome of globozoosper-
mic patients against normozoospermic subjects revealed aberrant 
expression of 35 proteins involved in spermatogenesis, metab-
olism, cytoskeleton and sperm function (Alvarez Sedo’, Rawe, & 
Chemes, 2012; Liao, Xiang, Zhu, & Fan, 2009). These included the 
overexpression of AKAP4 and actin, as well as the underexpression 
of enzymes of the Krebs cycle, tubulin and proteins associated with 
the outer dense fibres and acrosome membrane.
6  | OVERVIE W OF METABOLOMIC S
Metabolomics is one of most recent -OMICS techniques that 
was developed after genomics, transcriptomics and proteom-
ics to analyse the entire metabolome, the final products of the 
metabolism within a biological system (Zhang, Sun, Wang, Han, & 
Wang, 2012). The metabolites are small molecules, less than 1kDa 
derived from metabolic pathways, and include hormones, amino 
acids, lipids, carbohydrates and nucleotides. The composition of 
the metabolome determines the current phenotypic state of a cell 
and actively changes in response to cellular and extracellular stim-
uli, making metabolomics studies more informative than the other 
-OMICS approaches, particularly in the investigation of cellular 
response to exogenous stimuli or in case of pathology (Nicholson, 
Lindon, & Holmes, 1999). The total estimate of metabolites is 
approximately 6,500, which is significantly lower than the num-
ber of genes (25,000), messenger RNAs (100,000) and proteins 
(1,000,000) present in a human cell. However, the development 
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of new technologies facilitates the detection of maximum number 
of molecules (Wishart et al., 2013). Therefore, the investigation of 
a less number of molecules to be analysed makes metabolomics 
easier to be performed in a short period of time compared to other 
-OMICS approaches (Newgard, 2017). So far, the metabolomics 
studies were carried out using different human biological sys-
tems such as cells, tissues or fluids, including urine, blood plasma 
and serum, cerebrospinal fluid, saliva, follicular fluid, breast milk, 
tears and seminal plasma (Wishart et al., 2013; Zhang et al., 2012). 
Moreover, metabolomic studies have been conducted in several 
fields of human medicine such as pharmacology, toxicology, nu-
trition,	cancer,	metabolic	diseases	and	reproduction	 (Čuperlović-
Culf, Barnett, Culf, & Chute, 2010; Vivanco et al., 2011; Zhang 
et al., 2012).
In general, heterogeneous nature of the metabolites makes it 
challenging to perform metabolomics experiments, whereas the 
TA B L E  1   Potential protein biomarkers in different male infertility conditions
Condition Sample Results Reference
Varicocele Spermatozoa Heat shock proteins, mitochondrial and 
cytoskeleton proteins are mainly affected by 
varicocele disease
Proposed markers to discriminate between 
varicocele and healthy patients:
PKAR1A, AK7, CCT6B, HSPA2, ODF2, 
ATPase1A4, HSPA2, SPA17 and APOA1
(Agarwal, Sharma, Samanta, 
Durairajanayagam, & Sabanegh, 2015; 
Hosseinifar et al., 2013)
Proposed markers to discriminate between 
bilateral and unilateral varicocele: ENKUR, 
SEMG1, SEMG2, SPAM1, CABYR, PRDX2, 
FASN and FN1.
Proteins CRISP2, ARG2 and GNPDA1 uniquely 
expressed in unilateral patients compared with 
fertile controls
(Agarwal, Sharma, Durairajanayagam, Cui, 
et al., 2015; Ayaz et al., 2015; Panner 
Selvam, Agarwal, & Baskaran, 2019)
The expression of HSPA5, SOD1 and ATP5D 
improves after varicocelectomy
(Camargo et al., 2013; Del Giudice 
et al., 2013; Hosseinifar et al., 2014)
Unexplained male 
infertility (UMI)
Spermatozoa Proposed markers to discriminate between 
UMI and fertile patients: SPA17, ANXA2 and 
SERPINA5
(Panner Selvam et al., 2019)
Seminal plasma Biomarkers for success in couples undergone 
IVF: clusterin, epididymal secretory protein E1 
and PSA
(Kanannejad & Gharesi-Fard, 2019)
Testicular cancer Spermatozoa Altered proteins in asthenozoospermic 
testicular cancer spermatozoa: CCT3, ATP1A4, 
ATP5A1 and UQCRC2
(Panner Selvam et al., 2019)
Testicular tissue Proposed markers of testicular tumour germ 
cell: PIWIL1 and TMPRSS12
(Liu et al., 2013)
Glutathione S-transferase M3 was reported to 
be downregulated in case of seminoma, while 
GCP6, CDK10 and StarD7 overexpressed
(Leman et al., 2009; Zimmermann 
et al., 2006)
Overexpression of PAK4 protein in embryonal 
carcinoma
(Castillo et al., 2019)
Azoospermia Seminal plasma ECM1, TEX101 and NPC2 proteins were 
suggested for the discrimination of obstructive 
from non-obstructive azoospermia
(Drabovich et al., 2013; Yamakawa 
et al., 2007)
Higher expression of seminal LGALS3BP in men 
with successful TESE
(Freour et al., 2013).
Oligoasthenozoospermia Seminal plasma Proposed markers to discriminate between 
oligoasthenoteratozoospermic (OAT) and 
normozoospermic patients: KLK3, LTF 
SERPINA1, GAPDH, NPC2, M2BP and 
lipocalin−1
(Giacomini et al., 2015; Liu, Wang, 
et al., 2018)
Globozoospermia Spermatozoa Overexpression of AKAP4 and actin, as well as 
the underexpression of enzymes of the Krebs 
cycle, tubulin, and proteins associated with the 
outer dense fibres and acrosome membrane
(Liao et al., 2009)
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heterogeneity of the molecules is comparatively less with other 
-OMICS approaches (Patti, Yanes, & Siuzdak, 2012). This can be par-
tially overcome by using more efficient metabolite extraction and sep-
aration procedures, high-throughput platforms to scan and detect a 
large number of metabolites, and computational tools for storage, pro-
cessing and analysis of large data sets (Zhang et al., 2012). To analyse 
intracellular metabolites, cells are completely lysed to extract the me-
tabolites. The protocol used to extract the metabolites can introduce 
variability due to the selectively loss of particular molecules, while 
alteration of the metabolic profile can be due to mistakes induced 
by the operator or long processing time (Patti et al., 2012). However, 
metabolomic profiling of body fluids does not require pre-processing 
steps, which in turn reduces the sample preparation time and tech-
nical bias. Once sample has been collected, the metabolic activities 
in the cell must be arrested in order to reliably reflect the metabo-
lomic profile at the time of collection. This is achieved by freezing 
the	sample	 in	 liquid	nitrogen,	which	 is	stored	at	−80°C,	and	further	
extraction of metabolites (Gika, Theodoridis, & Wilson, 2008). Most 
commonly employed separation techniques for metabolomic studies 
include high-performance liquid chromatography (HPLC) and capil-
lary electrophoresis as well as gas chromatography (Fiehn, 2008; Juo, 
Chiu, & Shiao, 2008). The qualitative and quantitative analysis of me-
tabolites can be performed by several advanced techniques such MS, 
nuclear magnetic resonance (NMR) spectroscopy, near infrared (NIR) 
and Raman spectroscopy (Deepinder, Chowdary, & Agarwal, 2007; 
Lindon & Nicholson, 2008). The metabolite identification/detection 
capacity of these techniques is limited and can univocally identify 
metabolites from one-third of the approximately 10,000 spectra ob-
tained. However, these advanced techniques can be used comple-
mentarily to detect maximum number of metabolites starting from a 
very low amount of sample (Patti et al., 2012; Zamboni, Saghatelian, 
& Patti, 2015). Different databases such as HMDB, KEGG, PubChem, 
ChEBI, BioCyc/HumanCyc, LipidMAPS, ChemSpider, METLIN and 
Recon2 are used to identify the metabolites present in the given sam-
ple (Marco-Ramell et al., 2018). Analysis of the data can vary as fin-
gerprinting, footprinting and profiling approaches based on the final 
goal (Vivanco et al., 2011). Metabolomic fingerprinting is a compar-
ative analysis of metabolite profiles between two conditions rather 
than the identification of all metabolites present in the system. The 
footprinting aims to identify all the molecules which are released in the 
extracellular space, while metabolomics profiling analyses a pre-de-
termined set of metabolites involved in specific pathways (Vivanco 
et al., 2011). In fact, the comparison with a placebo-treated system or 
a healthy control makes possible the investigation of metabolic path-
ways directly altered by the treatment/disease and the identification 
of more reliable molecular biomarkers of disease.
7  | METABOLOMIC S AND MALE 
REPRODUC TION
In male reproduction, metabolomic studies have been conducted 
to shed light on the altered pathways in male infertility scenarios. 
The results from investigation of metabolites in sperm cells, seminal 
plasma and testicular tissue are described in the next sections.
7.1 | Sperm metabolomics
Metabolomics analysis of the spermatozoa is challenging due to 
the presence of seminal plasma and use of reagents for sperm 
washing that potentially interfere with metabolomics analysis. 
The first metabolomics study on spermatozoa was conducted in 
2015 by Paiva et al. using spermatozoa selected by density gradi-
ent. The metabolome of spermatozoa was analysed by combining 
results from proton nuclear magnetic resonance (1H-NMR) spec-
troscopy and gas chromatography–mass spectrometry (GC-MS) 
(Paiva et al., 2015), detecting a maximum number of metabolites 
(n = 69). For the first time, authors reported intracellular metabo-
lome of the spermatozoa such as amino acids, peptides and ana-
logues as the most representative molecules, followed by lipids 
organic acids, aliphatic acyclic compounds, carbohydrates and nu-
cleotides. The presence of lactate, carnitine and acetylcarnitine 
in important metabolomic pathways such as glycolysis and fatty 
acid oxidation and its association with sperm physiology provided 
foundation for further studies. Two years later, Reynolds et al. 
used 1H-NMR to profile the metabolome of spermatozoa selected 
by density gradient. Metabolome profiles of mature and immature 
fraction of spermatozoa revealed differences in lipid composition 
with a higher concentration of lactate, choline and glycerophos-
phocholine in immature fraction due to the presence of mor-
phological defects in the selected sperm population (Reynolds, 
Calvert, Paley, & Pacey, 2017).
Metabolomic profile of spermatozoa investigated by GC-MS 
in idiopathic asthenozoospermic patients revealed the under- and 
overexpression of 27 and 6 metabolites, respectively, when com-
pared to the healthy subjects (Zhao et al., 2018). Molecular path-
ways related to the metabolism of nucleosides, amino acids and 
sugars were altered in asthenozoospermic samples. Some essen-
tial amino acids, such as tryptophan and leucine, were significantly 
underexpressed, suggesting that sperm motility of asthenozo-
ospermic patients can be improved by exogenous amino acid sup-
plementation. Further, reduced levels of 3-phosphoglycerate and 
lactic acid suggested a disturbance in glycolysis and Krebs cycle 
pathways, with consequences on energy production. Targeted 
metabolomic experiments on semen before and after cryopres-
ervation showed disturbance in sugar metabolism associated with 
reduced semen motility following freezing/thawing processes (Fu 
et al., 2019). Metabolomics analysis revealed dysfunction of gly-
colysis pathway in cryopreserved spermatozoa, also supported 
by the underexpression of the hexokinases (HK2) enzyme, de-
tected by Western blotting. Finally, intracellular metabolic profile 
has been correlated with semen parameters by analysing semen 
samples from healthy volunteers (Engel et al., 2019). Specifically, 
alterations of the intracellular metabolites’ concentration such as 
acylcarnitines, lysophosphatidylcholines, phosphatidylcholines, 
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sphingomyelins and sugars have been closely associated with 
sperm motility. Although further studies are needed to identify 
the physiological concentration of such metabolites, these pre-
liminary results laid the foundation for the identification of more 
reliable molecular markers of semen quality.
7.2 | Seminal plasma metabolomics
The first metabolomics study on seminal plasma was published 
by Hamamah et al. in 1993, and analysed metabolomics profile 
of seminal plasma in infertile patients with obstructive azoo-
spermia, oligoasthenoteratozoospermia and spermatogenic failure 
(Hamamah et al., 1993) (Table 2). The results, obtained by 1H-NMR, 
were compared to those from a control group of normozoospermic 
men. Hamamah et al suggested that a combination of biomark-
ers, such as glycerylphosphorylethanolamine—GPC, citrate and 
lactate, might be used to differentiate obstructive azoospermic 
patients, while the ratios between citrate:lactate and GPC:lactate 
were altered in both oligoasthenoteratozoospermic and sper-
matogenic failure patients (Hamamah et al., 1993). The other me-
tabolites such as alanine, tyrosine and phenylalanine were also 
reported to be altered in infertile normozoospermic and oligozoo-
spermic patients (Gupta et al., 2011). Xu et al. used LC-MS tech-
nique to identify the difference in seminal metabolome between 
fertile and infertile patients (Xu, Lu, Wang, Zhang, & Wu, 2020). 
A total of 63 metabolites were identified as potential biomarkers 
of infertility, and 17 of these were correlated with semen param-
eters. The relationship was established between acylcarnitines 
and sperm concentration, sperm motility and antioxidant levels 
in semen. Furthermore, carnitines involved in the sperm matura-
tion process (Niederberger, 2005) also has an impact on oxidative 
stress (Dobrakowski et al., 2017).
The metabolic seminal profile was also analysed in male infertil-
ity-associated conditions such as spinal cord injury and obesity by 
MALDI-TOF MS, and Kidney Young deficiency syndrome (KYDS) by 
LC/QTOF-MS (Chen, Hu, Dai, & Chen, 2015; Guo et al., 2017; da 
Silva et al., 2011). In case of spinal cord injury, altered metabolites 
were associated with metabolism and biosynthesis of lipids, nucleo-
tides, response to oxidative stress and vitamins (da Silva et al., 2011), 
whereas KIDS seminal plasma metabolome showed altered biosyn-
thesis and metabolism of aromatic amino acids, sugars and lipids 
(Chen et al., 2015). Spermidine and spermine levels were increased 
in obese patients with abnormal semen quality, highlighting the role 
of these polyamines in the testicular development and spermato-
genesis (Guo et al., 2017).
Metabolomics of seminal plasma was also investigated in sev-
eral conditions related to sperm abnormalities. Jayaraman et al. used 
1H-NMR to analyse seminal plasma metabolome of oligozoospermic, 
asthenozoospermic, teratozoospermic, azoospermic and idiopathic 
infertile men (Jayaraman et al., 2014). Besides the altered metab-
olites, a unique metabolic profile was identified in idiopathic infer-
tility, characterised by altered levels of fructose, citrate and amino 
acids (lysine, arginine, tyrosine and proline). These metabolic dys-
functions in seminal plasma may explain the origin of idiopathic in-
fertility (Jayaraman et al., 2014). Similarly in the case of UMI, amino 
acid catabolism was increased, which indicates that oxidative stress 
is associated with the UMI aetiology (Jafarzadeh et al., 2015; Qiao 
et al., 2017).
Since 2014, different techniques have been used to profile 
the metabolome of asthenozoospermic patients. By performing 
1H-NMR, metabolomic dysregulations related to sugars, lipids 
and amino acids were reported in seminal plasma of asthenozo-
ospermic patients and indicate that oxidative stress mechanism is 
disturbed in asthenozoospermia (Jayaraman et al., 2014; Zhang, 
Diao, Zhu, Li, & Cai, 2015). Moreover, GC-MS identified increased 
levels of oleic and palmitic acids and reduced valine concentration 
that may cause membrane dysfunction and poor sperm motility, 
respectively (Tang et al., 2017). Furthermore, HPLC-ESI-MS/MS 
techniques was able to report the alteration of metabolites re-
lated to arachidonic acid metabolism (arachidonic acid, 15-HETE, 
8,9-EET, PGE2, 14,15-DHET, 14,15-EET, PGD2, 5-HETE, PGF2α, 
Tetranor-PGEM, 11,12-DHET, 20-HETE) (Yu et al., 2019), whereas 
metabolomic fingerprinting of seminal plasma assessed by Raman 
spectroscopy was able to discriminate asthenozoospermic from 
normozoospermic patients (Gilany, Moazeni-Pourasil, Jafarzadeh, 
& Savadi-Shiraz, 2014).
Engel et al. reported that the metabolomic profile of seminal 
plasma correlated with the sperm concentration and morphology 
in healthy donors using LC-MS/MS approach (Engel et al., 2019). 
Huang et al. reported an association between sperm concentration/
sperm count and products of fatty acid, lipid and amino acid me-
tabolism (Huang et al., 2019). Metabolomics platform was used to 
evaluate the relationship between the metabolites in seminal plasma 
and normal sperm morphology. Reduced levels of metabolites, such 
as amino acids, lactate, citrate, creatinine, α-ketoglutaric acid, sper-
mine and putrescine, were noticed in the seminal plasma of oligoas-
thenozoospermic patients (Mumcu, Karaer, Dogan, & Tuncay, 2019). 
On the other hand, amino acids, citric acid, choline, D-glucose, 
myo-inositol, lactate and pyruvate were significantly overexpressed 
in infertile teratozoospermic patients (Mehrparvar et al., 2020). In 
oligozoospermic patients, 1H-NMR detected altered levels of fruc-
tose, myo-inositol, aspartate and choline, involved in the sperm mat-
uration, energy metabolism and cell membrane composition (Murgia 
et al., 2020). Future in-depth studies are required to better inves-
tigate the seminal metabolome and identify biomarkers associated 
with sperm abnormalities.
Metabolomics has been recently applied to the field of assisted 
reproductive techniques (ART) to predict spermatogenesis in non-
obstructive azoospermic (NOA) patients (Gilany et al., 2017, 2018). 
Techniques such as GS-MS and Raman spectroscopy were able to 
identify 36 discriminatory metabolites in seminal plasma as well as 
to classify NOA patients based on the TESE outcome. Although the 
field of metabolomics in male reproductive research is still in emerg-
ing phase, metabolites are very promising non-invasive biomarkers 
for the diagnosis and management of male infertility.
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1H-NMR Glycerylphosphorylethanolamine, citrate and lactate 
varied in azoospermic men, while citrate:lactate ratios and 
GPC:lactate ratios were altered in spermatogenic failure 
and OA
Gupta et al. (2011) Infertile normozoospermic (65)
Infertile oligozoospermic (60)
Healthy fertile men (60)
1H-NMR Alanine, citrate, glycerylphosphorylcholine, tyrosine and 




Spinal cord injury (6)
Healthy controls (6)
MALDI-TOF MS Altered pathways in spinal cord injury patients: biosynthesis 
of nucleotides, sterol biosynthesis, arachidonic acid 










1H-NMR Idiopathic infertile men profile differed from that of fertile 
controls and other infertile groups due to either up- or 
downregulation of lysine, fructose, arginine, tyrosine, 
citrate and proline




Metabolomic fingerprinting could be used to discriminate 
between asthenozoospermic and normozoospermic males
Zhang et al., 2015 Asthenozoospermia (33)
Healthy men (30)
1H-NMR Asthenozoospermia associated with metabolic dysregulation 
of amino acids, lipids, phospholipids (choline), cholesterol, 
nucleosides, sugar and energy generation.
Overexpression of oxysterols indicated the role of oxidative 
stress in the mechanism of asthenozoospermia.
Chen et al. (2015) Infertile males with Kidney 
Yang Deficiency Syndrome 
(KYDS) (18)
Fertile men (18)
LC/QTOF-MS Changes in metabolic pathways of biosynthesis and 
metabolism of aromatic amino acids, citric acid cycle 
and sphingolipid metabolism may contribute to the 







Men with unexplained infertility have an imbalance of 
oxidative stress, increased biomarkers of oxidative stress 
and absence of a functional antioxidant system
Tang et al. (2017) Asthenozoospermia (30)
Healthy donors (30)
GC/MS Levels of oleic acid and palmitic acid were higher in 
asthenozoospermic men, which may signify a metabolic 
disorder of the sperm membrane.
Deficiency of valine may contribute to poor sperm motility
Qiao et al. (2017) UMI (80)
Fertile men (80)
GC/MS Increased catabolism of various amino acids. 
4-Hydroxyphenylacetic acid is a key metabolite in 
differentiating between UMI and controls, and its seminal 
plasma concentration related positively to sperm counts
Guo et al. (2017) Normal BMI, normal semen 
quality (55)
Obese, abnormal semen quality 
(9)
MALDI-TOF MS Spermidine and spermine significantly higher in obese men 
with abnormal semen quality. They were likely to play a 
vital role in the spermatogenesis progress.
Gilany et al. (2017) NOA with TESE-negative (11)
NOA with TESE-positive (9)
Fertile healthy men (10)
GS-MS 36 discriminatory metabolites for different groups in NOA 
condition
Gilany et al. (2018) NOA with TESE-negative (10)
NOA with TESE-positive (10)
Fertile healthy men (15)
Raman
spectroscopy
The seminal plasma metabolome could be used to detect 
spermatogenesis in NOA patients.
TESE-negative patients have severe oxidative imbalance 
compared to TESE-positive
(Yu et al., 2019) Asthenozoospermia (30)
Healthy men (33)
HPLC-ESI-MS/MS A significant disorder of arachidonic acid metabolism was 
observed in asthenozoospermic samples.
Engel et al. (2019) Healthy donors (20) LC-MS/MS Seminal plasma metabolites are closely related to sperm 
concentration and morphology
(Continues)
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7.3 | Testicular metabolomics
Metabolomics has been used as a non-invasive tool to investi-
gate the occurrence of spermatogenesis in the testicular tissue of 
non-obstructive azoospermic patients (Aaronson, Iman, Walsh, 
Kurhanewicz, & Turek, 2010; Liu et al., 2014). Analysis of frozen tes-
ticular tissue with 1H-NMR revealed increased phosphocholine (PC) 
in patients with normal spermatogenesis undergoing vasectomy, in 
comparison with patients showing maturation arrest or Sertoli cell 
only syndrome (Aaronson et al., 2010). Hence, PC can be used as a 
putative screening biomarker of spermatogenesis, as its concentra-
tion is indicative of cellular proliferation and membrane synthesis 
(Aaronson et al., 2010). Liu et al., (2014) identified 12 differentially 
expressed metabolites using GS-MS in fresh seminiferous tubules 
of non-obstructive and obstructive azoospermic patients, with in-
creased levels of cis-Phytol and glutamine, and decreased levels 
of saccharides and amino acids in non-obstructive testes. Further, 
Raman spectroscopy was able to distinguish the non-obstructive 
and obstructive azoospermic patients with high sensitivity (90%) and 
specificity (85.71%), emerging as a potential non-invasive tool to pre-
dict spermatogenesis in the seminiferous tubules (Liu et al., 2014).
8  | METABOLOMIC S IN PROGNOSIS AND 
DIAGNOSIS OF MALE INFERTILIT Y
The identification of biomarkers for prognosis, diagnosis and sever-
ity, as well as to predict the success of a therapeutic approach, is 
one of the main goal of metabolomics studies. An ideal biomarker 
should have high sensitivity and specificity, and its detection should 
be easy and noninvasive as well as fast and economically sustainable 
(Bieniek, Drabovich, & Lo, 2016). Moreover, using a combination or 
panel of biomarkers may increase their power as a prognostic and 
diagnostic tool. Metabolites present in the seminal plasma can serve 
as predictive biomarkers in several conditions associated with male 
infertility (Table 3). A group of metabolites (alanine, citrate, GPC, ty-
rosine and phenylalanine) was able to discriminate patients based 
on the fertility status as well as oligozoospermic from normozoo-
spermic patients with the accuracy of 92.4% and 92.9%, respectively 
(Gupta et al., 2011). Lysine was proposed as a potential biomarker 
to discriminate idiopathic infertile men from normozoospermic men 
(Jayaraman et al., 2014). Qiao et al. developed a model based on 153 
differentially expressed metabolites in seminal plasma to discrimi-
nate UMI patients from fertile healthy men with a specificity of 92% 
(Qiao et al., 2017). Particularly, 4-hydroxyphenylacetic acid posi-
tively correlated with the sperm count and considered as decisive in 
screening UMI patients. A group of metabolites composed by lactate, 
citrate, lysine, arginine, valine, glutamine, creatinine, α-ketoglutaric 
acid, spermine, putrescine and tyrosine was also recommended to 
discriminate normozoospermic and oligoasthenoteratozoosper-
mic samples (Mumcu et al., 2019), while altered levels of aspartate, 
choline, fructose and myo-inositol were reported in oligozoosper-
mic cases (Murgia et al., 2020). Metabolomics study conducted on 
sperm cells isolated by density gradient centrifugation suggested 
that 33 altered metabolites may be used as a molecular signature of 
idiopathic asthenozoospermia (Zhao et al., 2018). Metabolites con-
centration in blood and urine samples is used to predict the fertil-
ity status of men. Combination of urinary metabolites was used to 








1H NMR spectroscopy 
t
The differences were based on the metabolites lactate, 
citrate, lysine, arginine, valine, glutamine, creatinine, 
a-ketoglutaric acid, spermine, putrescine and tyrosine. 
Except the tyrosine, levels of the above metabolites were 
significantly decreased in patients with OAT compared to 
the controls.
Huang et al. (2019) Chinese men (98) UPLC-MS/MS 16 and 22 seminal plasma metabolites were related to sperm 
concentration and count, respectively, and they are mainly 
involved in fatty acid, lipid and amino acid metabolism.
Xu et al. (2020) Infertile men (140)
Healthy men (35)
LC-MS/MS 17 metabolites were found to be significantly correlated with 
sperm parameters.
All the potential biomarkers were involved in 14 metabolic 
pathways playing important role in energy production, 





1H-NMR 18 deregulated metabolites were identified in fertile men 





1H-NMR Fructose, myo-inositol, aspartate and choline were altered 
in oligozoospermia and also correlated with sperm motility 
profile
Abbreviations: BMI, body mass index; NOA, non-obstructive azoospermia; OA, obstructive azoospermia; OAT, oligoasthenoteratozoospermia; TESE, 
testicular sperm extraction.
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able to predict oligozoospermia with moderate sensitivity (65%) and 
specificity (71%) (Zhang et al., 2014). Idiopathic normozoospermic 
infertile men can be predicted using a combination of 5 biomark-
ers (leukotriene E4, carnitine, aspartate, xanthosine and methoxy-
tryptophan) (Zhang et al., 2014). In fact, higher sensitivity (85.7%) 
and specificity (86.8%) were noticed when they were all included 
in the predictive model in comparison with using the single mark-
ers. Like urine and seminal plasma, blood metabolites are analyzed 
and used as a non-invasive tool for differential disease diagnosis. A 
recent multivariate analysis identified a set of 38 metabolites from 
blood plasma to discriminate healthy controls from infertile men 
with semen abnormalities (sensitivity: 78.69%, specificity: 84.09%) 
and infertile men with erectile dysfunction (sensitivity: 80.33%, 
specificity: 100%) (Zhou et al., 2016). Metabolomics is emerging as a 
new promising tool for the diagnosis and prognosis of male infertil-
ity, and its application to the semen and other biological fluids will 
provide evidence on the metabolic dysfunctions associated with the 
male infertility.
9  | CHALLENGES AND FUTURE 
PERSPEC TIVES OF PROTEOMIC S AND 
METABOLOMIC S IN CLINIC AL ANDROLOGY
Adjunct use of biomarker screening along with standard semen 
analysis may increase the diagnostic power in evaluating the male 
TA B L E  3   Studies showing the diagnostic/prognostic power of metabolomics
References Sample/ Studied population Metabolomics techniques Main findings




(60) Healthy fertile men 
(60)
1H-NMR Alanine, citrate, GPC, tyrosine and phenylalanine 
can be used to determine infertility.
High accuracy in differentiating healthy 
controls from infertile patients (92.4%) and 
normozoospermic from oligozoospermic 
samples (92.9%)
Jayaraman et al. (2014) Seminal plasma







1H-NMR Lysine has the potential to aid in the detection 
and diagnosis of idiopathic infertility
Zhang et al. (2014) Urine
Normozoospermic infertile 
cases (n = 71) and fertile 




Leukotriene E4, 3-hydroxypalmitoylcarni- tine, 
aspartate, xanthosine and methoxytryptophan 
can discriminate normozoospermic infertile 
patients from fertile controls




LC/QTOF–MS The combined pattern of acetylcarnitine, 
carnitine C3:1 and aspartic acid provided 
moderate diagnostic power for oligozoospermic 
infertility




GC-MS Set of metabolites from plasma samples was 
proposed to discriminate healthy controls from 
infertile men with semen abnormalities and 
infertile men with erectile dysfunction
Qiao et al. (2017) Seminal plasma
UMI (80)
Fertile men (80)
GC/MS 153 seminal plasmatic metabolites were able 
to distinguish 82% of the UMI patients from 
healthy controls with a specificity of 92%




GC-MS Altered expression of metabolites was 
used to discriminate between idiopathic 
asthenozoospermic patients and healthy 
controls
Mumcu et al. (2019) Seminal plasma
OAT (31)
Normozoospermia (28)
1H NMR spectroscopy t A PLS-DA model built on the NMR data achieved 
89.29% sensitivity and 93.55% specificity 
results in a leave-one-out cross-validation 
process
Murgia et al. (2020) Seminal plasma
Oligozoospermia (18)
Normozoospermia (29)
1H-NMR NMR-based metabolomics allowed the 
identification of a specific metabolic fingerprint 
of the seminal fluids of patients affected by 
oligozoospermia
     |  13 of 18PANNER SELVAM Et AL.
infertility, particularly in case of idiopathic male infertility (Jungwirth 
et al., 2016). Male infertility is a multifactorial disorder and the use 
of a set of biomarkers instead of a single biomarker may significantly 
enhance the predictive power of pathological conditions (Zhang 
et al., 2014). Longo et al. (2018) reported that volatile metabolites 
(volatilome) were able to demonstrate a relationship between sperm 
metabolism and male infertility in astheno- and oligozoospermic 
patients. The identification of altered metabolic processes in male 
infertility scenarios by proteomics and metabolomics studies will 
open the avenue for the identification of novel therapeutic targets. 
Further studies based on larger and heterogeneous population are 
required to validate the preliminary markers identified in the clinical 
practice. The presence of confounding factors, such as age, gender, 
nationality, exposure to environmental factors, should be taken into 
consideration during the analysis.
10  | CONCLUSION
Proteomics and metabolomics are emerging as powerful tools to 
investigate the molecular causes of male infertility. The applica-
tion of high-throughput platforms for the detection of proteins and 
metabolites, combined with the use of sophisticated bioinformatic 
software for their analysis, will enable the identification of biomark-
ers for prognosis and diagnosis of male infertility and prediction of 
reproductive outcomes in the ART. The understanding of the mo-
lecular changes associated with male infertility will help in planning 
ad hoc treatments, with significant contribution in the clinical man-
agement of infertile patients.
11  | TAKE HOME MESSAGE
• Proteomics and metabolomics can decipher the molecular etiolo-
gies associated with male infertility conditions.
• Proteomics and metabolomics may allow the identification 
of more reliable markers of diagnosis and prognosis of male 
infertility.
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